Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer
Active, not recruitingOBSERVATIONAL
Enrollment
220
Participants
Timeline
Start Date
January 10, 2021
Primary Completion Date
June 20, 2023
Study Completion Date
January 10, 2026
Conditions
Metastatic Gastric Cancer
Trial Locations (1)
00144
IRCCS National Cancer institute, Rome
All Listed Sponsors
lead
Regina Elena Cancer Institute
OTHER
NCT06877910 - Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer | Biotech Hunter | Biotech Hunter